In Vivo assessment of antiviral reactivity in chronic HIV infection

HIV Clinical Trials

Volumn 1, Issue 3, 2000, Pages 16-22

  Smith, Kendall A ^a   Jacobson, Elizabeth Leef ^a   Sohn, Theresa ^a   Warren, David ^a   Emert, Roger ^a   Giordano, Michael ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CD8+ t lymphocytosis; HIV; Interleukin 2; Lymphocyte dynamics; Structured treatment interruption; Viral dynamics

Indexed keywords

INTERLEUKIN 2; VIRUS RNA;

ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; NATURAL KILLER CELL; PHYSIOLOGY; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; RNA, VIRAL;

EID: 0034329477     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/4VD1-WGAU-VX2L-V3JE     Document Type: Article

References (21)

1. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [see comments]. N Engl J Med. 1997;337:734-739.
2. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleotide analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
3. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia [see comments]. Science. 1997;278:1291-1295.
4. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [see comments]. Science. 1997;278:1295-1300.
5. Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5:512-517.
6. Zhang L, Ramratnam B, Tenner-Racz K, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. N Engl J Med. 1999;340:1605-1613.
7. Jubault V, Burgard M, Le Corfec E, Costagliolia D, Rouzioux C, Viard JP. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. AIDS. 1998;12:2358-2359.
8. Staszewski S, Miller V, Sabin C, Berger A, Hill AM, Phillips AN. Rebound of HIV-1 viral load after suppression to very low levels. AIDS. 1998;12:2360.
9. Davey RT Jr, Bhat N, Yoder C, et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci USA. 1999;96:15109-15114.
10. Chun, T-W, Engel D, Mizell SB, et al. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. War Med. 1999;5:651-655.
11. Garcia F, Plana M, Vidal C, et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. AIDS. 1999;13:F79-F86.
12. Callan MF, Steven N, Krausa P, et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med. 1996;2:906-911.
13. Wilson JD, Ogg GS, Allen RL, et al. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med. 1998;188:785-790.
14. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CDS T cells: A reevaluation of bystander activation during viral infection. Immunity. 1998;8:177-187.
15. Gallimore A, Glithero A, Godkin A, et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med. 1998;187:1383-1393.
16. Mongkolsapaya J, Jaye A, Callan MF, Magnusen AF, McMichael AJ, Whittle HC. Antigen-specific expansion of cytotoxic T lymphocytes in acute measles virus infection. J Virol. 1999;73:67-71.
17. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
18. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68:6103-6110.
19. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. Viral dynamics of acute HIV-1 infection. J Exp Med. 1999;190:841-850.
20. Matloubian M, Concepcion RJ, Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol. 1994;68: 8056-8063.
21. Murali-Krishna K, et al. In vivo dynamics of anti-viral CDS T cell responses to different epitopes: An evaluation of bystander activation in primary and secondary responses to viral infection. In: Gupta S, ed. Mechanisms of Lymphocyte Activation and Immune Regulation VII. New York: Plenum Press; 1998.